Anand K. Kondapi

2.6k total citations
79 papers, 2.1k citations indexed

About

Anand K. Kondapi is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Anand K. Kondapi has authored 79 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 18 papers in Infectious Diseases and 15 papers in Organic Chemistry. Recurrent topics in Anand K. Kondapi's work include Cancer therapeutics and mechanisms (23 papers), RNA Interference and Gene Delivery (15 papers) and HIV Research and Treatment (15 papers). Anand K. Kondapi is often cited by papers focused on Cancer therapeutics and mechanisms (23 papers), RNA Interference and Gene Delivery (15 papers) and HIV Research and Treatment (15 papers). Anand K. Kondapi collaborates with scholars based in India, United States and Australia. Anand K. Kondapi's co-authors include Sonali Kumari, Kishore Golla, Y.N. Vashisht Gopal, Prashant Kumar, Farhan Ahmed, Venkata S. Bollimpelli, Irfan Ahmad Ghazi, Insaf Ahmed Qureshi, Mir Zahoor Gul and Farhan Jalees Ahmad and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biochemistry.

In The Last Decade

Anand K. Kondapi

77 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anand K. Kondapi India 30 896 574 351 292 228 79 2.1k
Chiung‐Tong Chen Taiwan 29 1.2k 1.3× 265 0.5× 430 1.2× 220 0.8× 105 0.5× 84 2.8k
Konstantinos Dimas Greece 26 1.1k 1.2× 330 0.6× 453 1.3× 296 1.0× 157 0.7× 85 2.1k
Rosanna Filosa Italy 30 796 0.9× 732 1.3× 253 0.7× 125 0.4× 54 0.2× 83 2.4k
Tao Jiang China 27 1.2k 1.3× 650 1.1× 370 1.1× 145 0.5× 67 0.3× 167 2.5k
Hwa Jeong Lee South Korea 25 1.0k 1.1× 218 0.4× 345 1.0× 390 1.3× 46 0.2× 95 2.1k
Zahra Amirghofran Iran 36 1.2k 1.3× 455 0.8× 594 1.7× 186 0.6× 105 0.5× 172 3.6k
Abolfazl Barzegar Iran 23 877 1.0× 233 0.4× 169 0.5× 228 0.8× 67 0.3× 83 1.9k
Jinhua Dong China 30 1.4k 1.5× 763 1.3× 253 0.7× 147 0.5× 52 0.2× 118 2.6k
Yashpal S. Chhonker United States 25 809 0.9× 263 0.5× 130 0.4× 154 0.5× 101 0.4× 108 2.1k
Jaspreet Kaur Dhanjal India 21 870 1.0× 311 0.5× 325 0.9× 185 0.6× 44 0.2× 57 2.1k

Countries citing papers authored by Anand K. Kondapi

Since Specialization
Citations

This map shows the geographic impact of Anand K. Kondapi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anand K. Kondapi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anand K. Kondapi more than expected).

Fields of papers citing papers by Anand K. Kondapi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anand K. Kondapi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anand K. Kondapi. The network helps show where Anand K. Kondapi may publish in the future.

Co-authorship network of co-authors of Anand K. Kondapi

This figure shows the co-authorship network connecting the top 25 collaborators of Anand K. Kondapi. A scholar is included among the top collaborators of Anand K. Kondapi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anand K. Kondapi. Anand K. Kondapi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kondapi, Anand K., et al.. (2023). The topoisomerase II β -kinase associated with HIV-1 is a potential target for pyridine-bischalcones' anti-HIV-1 activity. European Journal of Medicinal Chemistry. 259. 115623–115623. 3 indexed citations
2.
Nagamani, K., Thrilok Chander Bingi, Kalyani Putty, et al.. (2021). Clinical and whole genome characterization of SARS-CoV-2 in India. PLoS ONE. 16(2). e0246173–e0246173. 7 indexed citations
3.
Kondapi, Anand K., et al.. (2021). Topoisomerase II β Gene Specific siRNA Delivery by Nanoparticles Prepared with c-ter Apotransferrin and its Effect on HIV-1 Replication. Molecular Biotechnology. 63(8). 732–745. 2 indexed citations
4.
Potshangbam, Angamba Meetei, et al.. (2020). Discovery of dual cation-π inhibitors of acetylcholinesterase: design, synthesis and biological evaluation. Pharmacological Reports. 72(3). 705–718. 9 indexed citations
5.
6.
Kumari, Sonali, Mohammad A. Saad, Jerald Mahesh Kumar, Anand K. Kondapi, & Nalam Madhusudhana Rao. (2017). Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433). Scientific Reports. 7(1). 6602–6602. 131 indexed citations
7.
Kondapi, Anand K., et al.. (2015). Montmorillonite K10 catalyzed multi component reactions (MCR): synthesis of novel thiazolidinones as anticancer agents. Heterocyclic Communications. 21(4). 187–190. 9 indexed citations
8.
Bollimpelli, Venkata S. & Anand K. Kondapi. (2015). Enriched rat primary ventral mesencephalic neurons as an in-vitro culture model. Neuroreport. 26(12). 728–734. 8 indexed citations
9.
Bollimpelli, Venkata S. & Anand K. Kondapi. (2015). Differential sensitivity of immature and mature ventral mesencephalic neurons to rotenone induced neurotoxicity in vitro. Toxicology in Vitro. 30(1). 545–551. 8 indexed citations
10.
Golla, Kishore, et al.. (2013). Biocompatibility, absorption and safety of protein nanoparticle-based delivery of doxorubicin through oral administration in rats. Drug Delivery. 20(3-4). 156–167. 25 indexed citations
11.
Kondapi, Anand K., et al.. (2013). Factors associated with conversion of long-term non-progressors to progressors: A prospective study of HIV perinatally infected paediatric survivors. SHILAP Revista de lepidopterología. 1 indexed citations
12.
Golla, Kishore, et al.. (2013). A Target-Specific Oral Formulation of Doxorubicin-Protein Nanoparticles: Efficacy and Safety in Hepatocellular Cancer. Journal of Cancer. 4(8). 644–652. 65 indexed citations
13.
Kondapi, Anand K., et al.. (2013). Involvement of human topoisomerase II isoforms in HIV-1 reverse transcription. Archives of Biochemistry and Biophysics. 532(2). 91–102. 10 indexed citations
14.
Rathore, R.S., et al.. (2013). HIV-1 Associated Topoisomerase IIβ Kinase: A Potential Pharmacological Target for Viral Replication. Current Pharmaceutical Design. 19(26). 4776–4786. 3 indexed citations
15.
Chaitanya, R.K., et al.. (2011). Curcumin-Loaded Apotransferrin Nanoparticles Provide Efficient Cellular Uptake and Effectively Inhibit HIV-1 Replication In Vitro. PLoS ONE. 6(8). e23388–e23388. 57 indexed citations
16.
Kondapi, Anand K., et al.. (2010). Neurotoxic activity of a Topoisomerase-I inhibitor, camptothecin, in cultured cerebellar granule neurons. NeuroToxicology. 31(6). 730–737. 13 indexed citations
17.
Mohan, Madan, et al.. (2009). Design, synthesis, and discovery of novel non-peptide inhibitor of Caspase-3 using ligand based and structure based virtual screening approach. Bioorganic & Medicinal Chemistry. 17(16). 6040–6047. 27 indexed citations
18.
Kondapi, Anand K., et al.. (2007). Distinct roles of Topoisomerase II isoforms: DNA damage accelerating α, double strand break repair promoting β. Archives of Biochemistry and Biophysics. 470(1). 27–34. 31 indexed citations
19.
Kondapi, Anand K., et al.. (2005). A biochemical analysis of topoisomerase II α and β kinase activity found in HIV-1 infected cells and virus. Archives of Biochemistry and Biophysics. 441(1). 41–55. 10 indexed citations
20.
Kondapi, Anand K., et al.. (2004). Analysis of age dependent changes of Topoisomerase II α and β in rat brain. International Journal of Developmental Neuroscience. 22(1). 19–30. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chiung‐Tong Chen Breakdown of academic impact, for papers by Konstantinos Dimas Breakdown of academic impact, for papers by Rosanna Filosa Breakdown of academic impact, for papers by Tao Jiang Breakdown of academic impact, for papers by Hwa Jeong Lee Breakdown of academic impact, for papers by Zahra Amirghofran Breakdown of academic impact, for papers by Abolfazl Barzegar Breakdown of academic impact, for papers by Jinhua Dong Breakdown of academic impact, for papers by Yashpal S. Chhonker Breakdown of academic impact, for papers by Jaspreet Kaur Dhanjal
Rankless by CCL
2026